NEW YORK, Feb. 27 - BioDiscovery and Genops Bioinformatics have announced plans to integrate their platform products.
The companies say the plan is to integrate BioDiscovery's GeneDirector with Genops' Ngene software and Linux cluster platform for high-throughput sequence analysis and annotation.
The firms explain that the goal of their agreement is "to provide a seamless product for integrated gene expression analysis." Both Ngene and GeneDirector have been designed as "expandable platforms" that can handle genomic- and proteomic-data integration.
Financial terms of the agreement were not disclosed.
"Our partnership aims to provide a cohesive data, experiment, and knowledge management core with the ability to ... analyze, compare, and annotate information generated from array experiments.... ," Soheil Shams, BioDiscovery's CEO, said in a statement.
This is not the first deal of its kind for Genops. Last September, the Vancouver, British Columbia-based company and bioinformatics startup Zerosum penned an information-sharing partnership designed to help Genops broaden its Ngene software while at the same time boost Zerosum's burgeoning business.
The deal also will help Zerosum, of Seven Valleys, Penn., expand its Bioinformatics Infrastructure Operations Center's life-science computing services.